New findings on long-term treatment of ADHD a

<p><strong>A large proportion of patients who start taking ADHD medication, especially young adults, stop within the first year. However, people who use ADHD medicine for a long time and in higher-than-average doses seem to have a higher risk of some cardiovascular diseases. This is according to two new studies led by researchers from Karolinska Institutet and published in <em>The Lancet Psychiatry</em> and <em>JAMA Psychiatry</em>. </strong></p>

Related Keywords

Dalsgaard ,Midtjylland ,Denmark ,Norway ,Netherlands ,Australia ,Hong Kong ,United States ,United Kingdom ,Iceland ,Sweden ,Swedish ,Brianm Donofrio ,Patrickd Quinn ,Yale Zhang ,Henrik Larsson ,Yanli Zhang James ,Ralf Kuja Halkola ,Theresa Wimberley ,Unnur Jakobsd ,Paul Lichtenstein ,Kari Klungs ,Pontus Andell ,Honghui Yao ,Patrick Ip ,Helga Zoega ,Stephenv Faraone ,Sallie Anne Pearson ,Hostrup Nielsen ,Anders Engeland ,Miguel Garcia Argibay ,Isabell Brikell ,Lin Li ,Catharina Hartman ,Harold Snieder ,Malcolmb Gillies ,Karolinska Institutet ,Kristina Johnell ,Le Gao ,Zheng Chang ,Jan Haavik ,Method Of Research ,Innovation Programme ,Swedish Research Council For Health ,Department Of Medical Epidemiology ,Lancet Psychiatry ,Medical Epidemiology ,Swedish Research Council ,Working Life ,Aske Astrup ,Tian Xie ,Juliana De Oliveira Costa ,Nina Pil Hostrup Nielsen ,Hyperactivity Disorder Medications ,Long Term Risk ,